Literature DB >> 26052818

Critical Intermediates Reveal New Biosynthetic Events in the Enigmatic Colibactin Pathway.

Zhong-Rui Li1, Yongxin Li1, Jennifer Y H Lai1, Jianqiang Tang2, Bin Wang3, Liang Lu1, Guoqiang Zhu4, Xiyang Wu5, Ying Xu2, Pei-Yuan Qian6.   

Abstract

Colibactin is a potent genotoxin that induces DNA double-strand breaks; it is produced by Escherichia coli strains harboring a pks+ island. However, the structure of this compound remains elusive. Here, using transformation-associated recombination (TAR) cloning to perform heterologous expression, we took advantage of the significantly increased yield of colibactin pathway-related compounds to determine and isolate a series of vital (pre)colibactin intermediates. The chemical structures of compounds 8, 10 and 11 were identified by NMR and MS(n) analyses. The new 1H-pyrrolo[3,4-c]pyridine-3,6(2H,5H)-dione- and thiazole-containing compound 10 provides new insights regarding the biosynthetic pathway to (pre)colibactin and establishes foundations for future investigation of the intriguing (pre)colibactin structures and its modes of action.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Escherichia coli; colibactin; heterologous expression; precolibactin; prodrug mechanism

Mesh:

Substances:

Year:  2015        PMID: 26052818     DOI: 10.1002/cbic.201500239

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  29 in total

Review 1.  Structure and bioactivity of colibactin.

Authors:  Kevin M Wernke; Mengzhao Xue; Alina Tirla; Chung Sub Kim; Jason M Crawford; Seth B Herzon
Journal:  Bioorg Med Chem Lett       Date:  2020-05-23       Impact factor: 2.823

Review 2.  Signaling Natural Products from Human Pathogenic Bacteria.

Authors:  Zhijuan Hu; Wenjun Zhang
Journal:  ACS Infect Dis       Date:  2019-10-30       Impact factor: 5.084

3.  Model Colibactins Exhibit Human Cell Genotoxicity in the Absence of Host Bacteria.

Authors:  Emilee E Shine; Mengzhao Xue; Jaymin R Patel; Alan R Healy; Yulia V Surovtseva; Seth B Herzon; Jason M Crawford
Journal:  ACS Chem Biol       Date:  2018-11-20       Impact factor: 5.100

Review 4.  Natural product discovery from the human microbiome.

Authors:  Matthew R Wilson; Li Zha; Emily P Balskus
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

Review 5.  Refining and expanding nonribosomal peptide synthetase function and mechanism.

Authors:  Matt McErlean; Jonathan Overbay; Steven Van Lanen
Journal:  J Ind Microbiol Biotechnol       Date:  2019-01-23       Impact factor: 3.346

6.  Structure and Functional Analysis of ClbQ, an Unusual Intermediate-Releasing Thioesterase from the Colibactin Biosynthetic Pathway.

Authors:  Naga Sandhya Guntaka; Alan R Healy; Jason M Crawford; Seth B Herzon; Steven D Bruner
Journal:  ACS Chem Biol       Date:  2017-09-08       Impact factor: 5.100

Review 7.  Employing chemical synthesis to study the structure and function of colibactin, a "dark matter" metabolite.

Authors:  Peyton C Williams; Kevin M Wernke; Alina Tirla; Seth B Herzon
Journal:  Nat Prod Rep       Date:  2020-11-18       Impact factor: 13.423

Review 8.  Molecular Basis of Gut Microbiome-Associated Colorectal Cancer: A Synthetic Perspective.

Authors:  Alan R Healy; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2017-10-12       Impact factor: 15.419

9.  MATE transport of the E. coli-derived genotoxin colibactin.

Authors:  Jarrod J Mousa; Ye Yang; Sarah Tomkovich; Ayaka Shima; Rachel C Newsome; Prabhanshu Tripathi; Eric Oswald; Steven D Bruner; Christian Jobin
Journal:  Nat Microbiol       Date:  2016-01-11       Impact factor: 17.745

10.  ClbS Is a Cyclopropane Hydrolase That Confers Colibactin Resistance.

Authors:  Prabhanshu Tripathi; Emilee E Shine; Alan R Healy; Chung Sub Kim; Seth B Herzon; Steven D Bruner; Jason M Crawford
Journal:  J Am Chem Soc       Date:  2017-11-28       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.